ObsEva is advancing a robust pipeline of novel, orally-administered, clinical-stage compounds in the areas of uterine fibroids, endometriosis, assisted reproductive technology, and preterm labor.
ObsEva SA
[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”OBSV” api=”yf” style=”font-size: 15px”]
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttp://www.obseva.com
Founded2012
Disease Focus
Development Stage
STOCK CODENASDAQ: OBSV
Address1228 Plan-les-OuatesGenevaSwitzerland
1228 Plan-les-Ouates
Geneva
Switzerland
Contact Number+41 0 22 552 3840
+41 0 22 552 3840
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/obseva-sa” connections=”true” suffix=””]